Structured evidence table for Chlorella Metabolic Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Chlorella Metabolic Health Randomized Trial | Conversely, catalase (WMD = 22.06 U/g.Hb; 95% CI: 3.19 to 40.93) increased significantly. | 1 | Mardani H (2026) | Beneficial effects of Chlorella species supplementation in the general population: a GRADE-assessed systematic review and dose-response meta-analysis. |
| Chlorella Metabolic Health Randomized Trial | While the evidence for BMI was rated as low, the certainty of evidence for most other outcomes was very low according to the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE). | 1 | Mardani H (2026) | Beneficial effects of Chlorella species supplementation in the general population: a GRADE-assessed systematic review and dose-response meta-analysis. |
| Chlorella Metabolic Health Randomized Trial | Our findings underscore the potential of Chlorella supplementation to support metabolic health in general population; however, given the overall very low certainty of evidence based on the GRADE assessment, these results should be interpreted cautiously. | 1 | Mardani H (2026) | Beneficial effects of Chlorella species supplementation in the general population: a GRADE-assessed systematic review and dose-response meta-analysis. |
| Chlorella Metabolic Health Randomized Trial | This systematic review and meta-analysis aimed to evaluate the potential benefits of Chlorella supplementation in the general population, with a focus on its impact across a broad spectrum of health-related biomarkers and clinical parameters. | 1 | Mardani H (2026) | Beneficial effects of Chlorella species supplementation in the general population: a GRADE-assessed systematic review and dose-response meta-analysis. |
| Chlorella Metabolic Health Randomized Trial | Plant-derived bioactive peptides have garnered widespread interest for their functions in managing obesity and associated metabolic disorders. | 4 | Lin L (2026) | A <i>Chlorella pyrenoids</i> Hexapeptide VPIIMH Alleviates Lipid Accumulation and Oxidative Stress in <i>Caenorhabditis elegans</i>: Insight from In Vitro, In Vivo, and Network Parmacology Analyses. |
| Chlorella Metabolic Health Randomized Trial | elegans model, treatment with 0.5 mg/mL VPIIMH significantly reduced fat accumulation by 37.2% and triglyceride levels by 26.9%. | 4 | Lin L (2026) | A <i>Chlorella pyrenoids</i> Hexapeptide VPIIMH Alleviates Lipid Accumulation and Oxidative Stress in <i>Caenorhabditis elegans</i>: Insight from In Vitro, In Vivo, and Network Parmacology Analyses. |
| Chlorella Metabolic Health Randomized Trial | This study investigated the lipid-lowering activity and underlying mechanisms of VPIIMH, a hexapeptide derived from Chlorella pyrenoids , using in vitro enzymatic assays, Caenorhabditis elegans models, and network pharmacology. | 4 | Lin L (2026) | A <i>Chlorella pyrenoids</i> Hexapeptide VPIIMH Alleviates Lipid Accumulation and Oxidative Stress in <i>Caenorhabditis elegans</i>: Insight from In Vitro, In Vivo, and Network Parmacology Analyses. |
Source documents